TCRR
RhumbLine Advisers’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-35,135
| Closed | -$97K | – | 3306 |
|
|
2022
Q1 | $97K | Sell |
35,135
-2,932
| -8% | -$8.1K | ﹤0.01% | 2892 |
|
|
2021
Q4 | $177K | Sell |
38,067
-617
| -2% | -$2.87K | ﹤0.01% | 2858 |
|
|
2021
Q3 | $329K | Buy |
38,684
+1,435
| +4% | +$12.2K | ﹤0.01% | 2733 |
|
|
2021
Q2 | $611K | Buy |
37,249
+375
| +1% | +$6.15K | ﹤0.01% | 2473 |
|
|
2021
Q1 | $814K | Sell |
36,874
-10
| -0% | -$221 | ﹤0.01% | 2284 |
|
|
2020
Q4 | $1.14M | Buy |
36,884
+6,433
| +21% | +$199K | ﹤0.01% | 2080 |
|
|
2020
Q3 | $619K | Buy |
30,451
+8,191
| +37% | +$167K | ﹤0.01% | 2189 |
|
|
2020
Q2 | $342K | Buy |
22,260
+9,922
| +80% | +$152K | ﹤0.01% | 2518 |
|
|
2020
Q1 | $95K | Buy |
12,338
+1,270
| +11% | +$9.78K | ﹤0.01% | 2789 |
|
|
2019
Q4 | $158K | Buy |
11,068
+278
| +3% | +$3.97K | ﹤0.01% | 2805 |
|
|
2019
Q3 | $162K | Buy |
+10,790
| New | +$162K | ﹤0.01% | 2797 |
|